Equatorial Guinea vs Gabon: HIV/AIDS deaths averted by antiretroviral therapy
HIV/AIDS deaths averted by antiretroviral therapy over time
- Equatorial Guinea
- Gabon
How they compare
Gabon currently reports 2,398 deaths against 2,224 deaths in Equatorial Guinea, a difference of 174 deaths.
That makes Gabon's figure about 1.1 times Equatorial Guinea's.
The two have swapped places 1 time across 33 shared years of data; in 1990 it was Gabon ahead.
Equatorial Guinea ranks 54th and Gabon ranks 53rd of 157 countries.
Across the 4 decades both report, Equatorial Guinea averaged higher in 1 and Gabon in 2.
Head to head by decade
| Decade | Equatorial Guinea | Gabon | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 0 deaths | 0 deaths | 0 deaths | — |
| 2000s | 135.6 deaths | 658.44 deaths | 522.84 deaths | Gabon |
| 2010s | 1,274 deaths | 2,011 deaths | 737.3 deaths | Gabon |
| 2020s | 2,173 deaths | 1,952 deaths | 221.1 deaths | Equatorial Guinea |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv/aids deaths averted by antiretroviral therapy, Equatorial Guinea or Gabon?
- Gabon, at 2,398 deaths against 2,224 deaths in Equatorial Guinea as of 2024.
- What is the difference in hiv/aids deaths averted by antiretroviral therapy between Equatorial Guinea and Gabon?
- 174 deaths, with Gabon ahead.
- How many years of comparable data are there for Equatorial Guinea and Gabon?
- 33 years are reported by both, from 1990 to 2022.
- How do Equatorial Guinea and Gabon rank globally for hiv/aids deaths averted by antiretroviral therapy?
- Equatorial Guinea ranks 54th and Gabon ranks 53rd of 157 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as HIV/AIDS deaths averted by antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths prevented as a direct result of Antiretroviral Therapy (ART) among people living with HIV. It is calculated by comparing the observed mortality rates in individuals receiving ART to the estimated mortality rates in the absence of such treatment. This is the central estimate.